Qin, B. Y., Chacko, B. M., Lam, S. S., de Caestecker, M. P., Correia, J. J., and Lin, K. (2001). Structural basis of Smadl activation by receptor kinase phosphorylation. Mol. Cell 8, 1303-1312.

Qin, B. Y„ Lam, S. S„ Correia, J. J., and Lin, K. (2002). Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control. Genes Dev. 16, 1950-1963. Qing, J., Zhang, Y., and Derynck, R. (2000). Structural and functional characterization of the transforming growth factor-beta -induced Smad3/c-Jun transcriptional cooperativity. J. Biol. Chem. 275,38802-38812.

Qing, J., Liu, C., Choy, L., Wu, R. Y., Pagano, J. S., and Derynck, R. (2004). Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol. Cell. Biol. 24, 1411-1425. Randall, R. A., Germain, S., Inman, G. J., Bates, P. A., and Hill, C. S. (2002). Different Smad2 partners bind a common hydrophobic pocket in Smad2 via a defined proline-rich motif. EMBO J. 21, 145-156.

Roberts A. B., and Sporn, M. B. (1990) The transforming growth factor-betas. In Peptide growth factors and their receptors, Eds Sporn M. B., and Roberts, A. B. (Springer-Verlag, Heidelberg) 419-472.

Roberts, A. B., Russo, A., Felici, A., and Flanders, K. C. (2003). Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann. NY. Acad. Sci. 995, 1-10. Roberts, A. B., and Wakefield, L. M. (2003). The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100, 8621-8623.

Rodriguez, C., Huang, L. J., Son, J. K., McKee, A., Xiao, Z., and Lodish, H. F. (2001). Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-beta signaling. J. Biol. Chem. 276, 30224-30230.

Roth, S. Y., Denu, J. M., and Allis, C. D. (2001). Histone acetyltransferases. Annu. Rev. Biochem. 70, 81-120. Sano, Y., Harada, J., Tashiro, S., Gotoh-Mandeville, R., Maekawa, T., and Ishii, S. (1999). ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling. J. Biol. Chem. 274, 8949-8957. Schmidt, D„ and Muller, S. (2003). PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci. 60, 2561-2574. Seoane, J., Pouponnot, C., Staller, P., Schader, M., Eilers, M., and Massague, J. (2001). TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor pl5INK4b. Nat. Cell Biol. 3, 400-408.

Seoane, J., Le, H. V., and Massague, J. (2002). Myc suppression of the p2 l(Cipl) Cdk inhibitor influences the outcome of the p53

response to DNA damage. Nature 419, 729-734.

Seoane, J., Le, H. V., Shen, L., Anderson, S. A., and Massague, J.

(2004). Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117,

0 0

Post a comment